E-LIB Suche - Ergebnisse für: Bashraheel, Sara S

1

Metformin and HER2-positive breast cancer: Mechanisms and t..:

Bashraheel, Sara S ; Kheraldine, Hadeel ; Khalaf, Sarah.
Biomedicine & Pharmacotherapy. 162 (2023) - p. 114676 , 2023

Link: https://doi.org/10.1016/..

2

Correction: Isolation and molecular characterization of nov..:

Rashidi, Fatma B. ; Al-Qahtani, Alanod D. ; Bashraheel, Sara S....
PLOS ONE. 18 (2023) 11 - p. e0294885 , 2023

Link: https://doi.org/10.1371/..

3

Novel SPEA Superantigen Peptide Agonists and Peptide Agonis..:

Bashraheel, Sara S. ; Goda, Sayed K.
International Journal of Molecular Sciences. 24 (2023) 13 - p. 10507 , 2023

Link: https://doi.org/10.3390/..

4

Update on targeted cancer therapies, single or in combinati..:

Bashraheel, Sara S ; Domling, Alexander ; Goda, Sayed K
Biomedicine & Pharmacotherapy. 125 (2020) - p. 110009 , 2020

Link: https://doi.org/10.1016/..

5

In vitrostudies on CNGRC-CPG2 fusion proteins for ligand-di..:

Al-mansoori, Layla ; Bashraheel, Sara S. ; Qahtani, Alanod D. Al...
Oncotarget. 11 (2020) 6 - p. 619-633 , 2020

Link: https://doi.org/10.18632..

6

Production of "biobetter" glucarpidase variants to improve ..:

AlQahtani, Alanod D. ; Al-mansoori, Layla ; Bashraheel, Sara S....
European Journal of Pharmaceutical Sciences. 127 (2019) - p. 79-91 , 2019

Link: https://doi.org/10.1016/..

7

Studies on vascular response to full superantigens and supe..:

Bashraheel, Sara S. ; AlQahtani, Alanod D. ; Rashidi, Fatma B....
Biomedicine & Pharmacotherapy. 115 (2019) - p. 108905 , 2019

Link: https://doi.org/10.1016/..

8

Production of "biobetter" variants of glucarpidase with enh..:

Al-Qahtani, Alanod D. ; Bashraheel, Sara S. ; Rashidi, Fatma B....
Biomedicine & Pharmacotherapy. 112 (2019) - p. 108725 , 2019

Link: https://doi.org/10.1016/..

9

Isolation and molecular characterization of novel glucarpid..:

Rashidi, Fatma B. ; AlQhatani, Alanod D. ; Bashraheel, Sara S....
PLOS ONE. 13 (2018) 4 - p. e0196254 , 2018

Link: https://doi.org/10.1371/..

10

Correction:Isolation and molecular characterization of nove..:

Rashidi, Fatma B ; Al-Qahtani, Alanod D ; Bashraheel, Sara S...
https://research.rug.nl/en/publications/b2fe105e-b0e1-4701-82a5-f64f629653fe. , 2023

Link: https://hdl.handle.net/1..

11

Novel SPEA Superantigen Peptide Agonists and Peptide Agonis..:

Bashraheel, Sara S ; Goda, Sayed K
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341475/. , 2023

Link: http://www.ncbi.nlm.nih...

12

In vitro studies on CNGRC-CPG2 fusion proteins for ligand-d..:

Al-Mansoori, Layla ; Bashraheel, Sara S ; Qahtani, Alanod D Al...
https://research.rug.nl/en/publications/b7ba6ce2-899a-4950-83a3-590df481fd04. , 2020

Link: https://hdl.handle.net/1..

13

Update on targeted cancer therapies, single or in combinati..:

Bashraheel, Sara S ; Domling, Alexander ; Goda, Sayed K
https://research.rug.nl/en/publications/0d2bfc05-16f3-41f0-adb4-b319d2f6af45. , 2020

Link: https://hdl.handle.net/1..

14

Production of "biobetter" glucarpidase variants to improve ..:

AlQahtani, Alanod D ; Al-mansoori, Layla ; Bashraheel, Sara S...
https://research.rug.nl/en/publications/01710d43-7742-48f9-9073-f01d45db71a1. , 2019

Link: https://hdl.handle.net/1..

15

Production of "biobetter" variants of glucarpidase with enh..:

Al-Qahtani, Alanod D ; Bashraheel, Sara S ; Rashidi, Fatma B...
https://research.rug.nl/en/publications/55a1476c-b5a0-452a-bf6a-a545bcd46b03. , 2019

Link: https://hdl.handle.net/1..